文献速递肥胖与代谢综合征

镁耗竭、代谢障碍与心脏改变:NAKO-MRI研究与孟德尔随机化

Magnesium Depletion, Metabolic Impairment, and Cardiac Alterations: The NAKO-MRI Study With Mendelian Randomization.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

该研究基于德国国家队列9568名接受全身MRI的参与者,横断面分析显示血清镁每升高1个标准差与代谢综合征患病率降低相关(OR 0.93),而镁耗竭评分升高与代谢综合征患病率增加(OR 1.32)及左心室重构指标改变相关。孟德尔随机化未支持血清镁与心脏结构形态的因果关联。

要点

  • 血清镁升高与代谢综合征患病率降低相关(OR 0.93)。
  • 镁耗竭评分升高与代谢综合征及左心室 concentric hypertrophy 相关。
  • 孟德尔随机化未支持血清镁对心脏结构形态的因果作用。

核心结论

  • 镁耗竭可能是心脏损害的早期指标,但孟德尔随机化结果不支持血清镁对心脏结构形态的因果作用。

研究设计与样本

  • 横断面分析德国国家队列基线9568名接受全身MRI的参与者,并采用两样本孟德尔随机化评估因果关联。

主要发现

  • 血清镁每升高1个标准差与代谢综合征患病率降低相关(OR 0.93 [95%CI 0.88-0.99])并降低左右心室收缩与舒张容积。
  • 镁耗竭评分每升高1单位与代谢综合征患病率增加相关(OR 1.32 [95%CI 1.23-1.41])及其各组分。
  • 镁耗竭评分升高与左心室重构指数增加(estimate 0.012 g/mL [95%CI 0.008-0.017])和左心室舒张末期容积降低(estimate -1.132 mL/m2 [95%CI -1.538至-0.727])相关。
  • 两样本孟德尔随机化提示血清镁与MRI衍生心脏标志物无因果关联。

临床怎么用

  • 镁耗竭评分可作为代谢综合征及亚临床心脏结构改变的早期风险标志物。
  • 血清镁与镁耗竭评分反映不同维度,需结合评估镁状态。

局限性

  • 横断面设计无法确定时序因果关系。
  • 孟德尔随机化结果不支持因果性,提示观察性关联可能受混杂影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Magnesium deficiency may contribute to subclinical cardiac changes, particularly metabolic diastolic cardiomyopathy. OBJECTIVE: To investigate the association between magnesium depletion, metabolic syndrome (MetS), and magnetic resonance imaging (MRI)-derived cardiac alterations in a population-based sample. METHODS: We cross-sectionally analyzed participants (N = 9568) from the baseline examination of the German National Cohort who underwent whole-body MRI. Associations of serum magnesium and magnesium depletion score (MDS) with MetS and cardiac alterations were assessed using multivariable logistic and linear regression, respectively. Two-sample Mendelian Randomization was performed to evaluate the potential causal relationship between serum magnesium and MRI-derived cardiac parameters. RESULTS: Our analysis revealed no correlation between serum magnesium and MDS (Spearman's rho = 0.065; P < .001). A 1-SD increase in serum magnesium was associated with lower MetS prevalence (odds ratio, 0.93 [95% CI, 0.88-0.99]) and reduced left and right ventricular systolic and diastolic volumes. Higher MDS, indicating magnesium deficiency, was linked to increased MetS prevalence (OR per 1 unit, 1.32 [95% CI, 1.23-1.41]) and its individual components. Furthermore, higher MDS was associated with increased left ventricular remodeling index (estimate, 0.012 g/mL [95% CI, 0.008-0.017]) and decreased left ventricular end-diastolic volume (estimate, -1.132 mL/m2 [95% CI, -1.538 to -0.727]), indicating concentric hypertrophy. Two-sample Mendelian Randomization suggested no causal relationship between serum magnesium and MRI-derived cardiac markers. CONCLUSION: Magnesium depletion may serve as an early indicator of cardiac impairment. However, Mendelian Randomization results do not support a causal role of serum magnesium on cardiac structure and morphology.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Shugaa Addin N, Schuppert C, Full PM, et al. Magnesium Depletion, Metabolic Impairment, and Cardiac Alterations: The NAKO-MRI Study With Mendelian Randomization. J Clin Endocrinol Metab. 2026. PMID: 40839755. doi:10.1210/clinem/dgaf476

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。